
CAS 185039-89-8
:PD0166285
Description:
PD0166285, with the CAS number 185039-89-8, is a chemical compound that has garnered interest in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized as a small molecule with a specific structure that allows it to interact with biological targets, often related to the modulation of signaling pathways. The compound is typically evaluated for its pharmacological properties, including its efficacy, selectivity, and safety profile in various biological assays. PD0166285 may exhibit properties such as solubility in organic solvents, stability under physiological conditions, and the ability to penetrate cellular membranes, which are crucial for its function as a drug candidate. Additionally, its synthesis involves standard organic chemistry techniques, and it may be analyzed using methods like NMR, mass spectrometry, and chromatography to confirm its identity and purity. Overall, PD0166285 represents a class of compounds that are actively researched for their potential roles in treating specific diseases or conditions.
Formula:C26H27Cl2N5O2
Synonyms:- Pyrido[2,3-d]pyriMidin-7(8H)-one, 6-(2,6-dichlorophenyl)-2-[[4-[2-(diethylaMino)ethoxy]phenyl]aMino]-8-Methyl-
- PD 0166285;PD-0166285
- PD0166285
- 6-(2,6-Dichloro-phenyl)-2-[4-(2-diethylaMino-ethoxy)-phenylaMino]-8-Methyl-8H-pyrido[2,3-d]pyriMidin-7-one
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
6-(2,6-Dichloro-phenyl)-2-[4-(2-diethylaMino-ethoxy)-phenylaMino]-8-Methyl-8H-pyrido[2,3-d]pyriMidin-7-one
CAS:Formula:C26H27Cl2N5O2Purity:98%Color and Shape:SolidMolecular weight:512.4309PD0166285
CAS:<p>PD0166285 is a potent Wee1 and Chk1 inhibitor with activity at nanomolar concentrations.PD0166285 is a novel G2 checkpoint abrogator.</p>Formula:C26H27Cl2N5O2Purity:99.23%Color and Shape:SolidMolecular weight:512.43PD 0166285
CAS:Controlled Product<p>PD 0166285 is an inhibitor of kinase activity. It binds to ATP-binding sites on the epidermal growth factor receptor (EGFR), preventing binding of the ligand and inhibiting downstream signaling pathways. PD 0166285 has been shown to inhibit the proliferation of human HL60 cells and skin cancer cells in culture. This drug also inhibits hyperproliferative diseases, including skin cancer, breast cancer, and lung cancer. PD 0166285 induces apoptosis through activation of caspases 3 and 7, which are key enzymes involved in programmed cell death. In addition, it inhibits angiogenesis by blocking the production of vascular endothelial growth factor (VEGF) from vascular endothelial cells that line blood vessels. PD 0166285 also blocks urothelial carcinoma progression by inducing apoptosis in these cells.</p>Formula:C26H27Cl2N5O2Purity:Min. 95%Molecular weight:512.43 g/mol




